Summary
Updated Aug 31, 2026
Frank Yocca is Chief Scientific Officer of BioXcel Therapeutics, Inc. (BTAI). 9 SEC Form 4 filings on record going back to 2024, most recently on 18 June 2026. Most recent open-market trade: sold $7K of BTAI on 22 May 2026. Lifetime open-market sales: $12K.
Recent Transactions
15Every recent SEC Form 4 transaction Frank Yocca has reported, most recent first.
Trading Pattern
InsiderAlpha's records for Frank Yocca go back to 2024: 9 primary Form 4 filings, an average of 3.0 per year. 11 recorded transactions carry a Rule 10b5-1 flag, meaning they were pre-scheduled under a written trading plan rather than discretionary.
Other Insiders Active in the Same Stocks
Insiders who reported open-market trades in the last 12 months at the companies Frank Yocca files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Vimal Mehta - $21K of BTAI open-market activity in the last 12 months
- Richard I. Steinhart - $7K of BTAI open-market activity in the last 12 months
- Javier Rodriguez - $7K of BTAI open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Frank Yocca?
Frank Yocca is a corporate insider, tracked as Chief Scientific Officer of BioXcel Therapeutics, Inc. (BTAI). InsiderAlpha holds 9 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Frank Yocca submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Has Frank Yocca been buying or selling stock?
Recorded transactions: 0 open-market purchases and 4 open-market sales ($12K) across all tracked filings.
Where can I see all of Frank Yocca's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Frank Yocca and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial